28Feb 2025
Tirzepatide Treatment Reduces Body Weight and Fat Mass in Obesity

Tirzepatide Treatment Reduces Body Weight and Fat Mass in Obesity

Tirzepatide significantly reduced body weight, fat mass, and lean mass in participants with obesity or overweight. In this substudy of 160 participants from the SURMOUNT‐1 trial, tirzepatide (n=124) led to a 21.3% reduction in body weight, 33.9% in fat mass, and 10.9% in lean mass, compared to placebo (n=36), which showed 5.3%, 8.2%, and 2.6% reductions, respectively (p<0.001). Fat mass loss was predominant across subgroups.

  • #endo-diabetology

Like

Save

Share